Table 2 Age specific attribution of precancerous cervical lesions to vaccine HPV genotypes attending three estimate methods

Method

Women age (years)

HPV 16/18 (%)

HPV 31/33/45/52/58 (%)

p

HPV 16/18 (%)

HPV 31/33/45/52/58 (%)

p

HPV 16/18 (%)

HPV 31/33/45/52/58 (%)

p

Minimum estimate

18–34

64

25

71

14

*

69

17

*

35–44

52

39

68

13

62

22

*

≥45

33

33

52

24

45

27

*

p-trend

*

Proportional attribution

18–34

53

29

*

74

13

*

66

19

*

35–44

48

41

*

64

16

*

59

24

*

≥45

48

26

44

28

*

46

27

*

p-trend

*

*

Hierarchical attribution

18–34

63

23

*

78

12

*

72

16

*

35–44

51

40

*

66

19

*

62

26

*

≥45

50

25

45

32

*

47

29

*

p-trend

*

*